Animal Health

At Animal Health we focus our research and development activities on antiparasitics, antibiotics, medicines to treat noninfectious disorders and nonantibiotic alternatives for infectious diseases. We improve the health and well-being of companion and farm animals through innovations. Animal Health pursues the “one health” concept: We offer animal health products that reduce the risk of transmission of disease pathogens to humans, such as endoparasiticides for cats and dogs or ectoparasiticides to protect especially against fleas and ticks. Through our initiative focusing on companion vector-borne diseases (CVBD™) and with the leading global scientists who participate in this initiative, we are setting trends in basic research and the fight against vector-borne diseases. In our central research activities, we cooperate closely with the research departments at Pharmaceuticals and Crop Science.

New products and registrations

In January 2017, the European regulatory authorities approved PolyVar™ yellow, a new product to protect honey bees against the Varroa mite. This decision was implemented in national law in more than 20 countries during the year.

Cooperations

Animal Health also reinforces its business by continually identifying further product development candidates through new and existing collaborations. We work closely together with our partners in areas such as the development of innovative technologies, application innovations and lead structure optimizations.